Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STACCATO: Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis
NCT03586284Phase 3Terminated
- Sponsor
- University of California, San Francisco
- Start
- Mar 2020
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 3 trial of valganciclovir, ganciclovir in Cytomegalovirus anterior uveitis, sponsored by University of California, San Francisco. Started Mar 2020; status: terminated.
02
Drugs
valganciclovirganciclovir
03
Conditions
Cytomegalovirus anterior uveitis
Beyond the preview
Go deeper on NCT03586284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03586284.